These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7569795)

  • 41. [Clinical manifestations of urinary disorders and their treatment in ageing men].
    Ourad W; Chaïbi P; Thomas C; Lahlou A; Hached D; Bussy C; Piette F; Robain G
    Presse Med; 2003 Jun; 32(23):1085-93. PubMed ID: 12910167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Currently available treatment guidelines for men with lower urinary tract symptoms.
    Roehrborn CG
    BJU Int; 2008 Nov; 102 Suppl 2():18-23. PubMed ID: 19032606
    [No Abstract]   [Full Text] [Related]  

  • 43. Challenging the maximum flow rate: a new index of voiding dysfunction in men with benign prostatic enlargement.
    Valentini FA; Nelson PP; Besson GR; Zimmern PE
    BJU Int; 2008 Apr; 101(8):995-9. PubMed ID: 18241248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Gerber GS
    Urology; 1996 Nov; 48(5):668-75. PubMed ID: 8911507
    [No Abstract]   [Full Text] [Related]  

  • 45. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
    Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
    BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Revised thinking in benign prostatic hyperplasia syndrome].
    Höfner K
    MMW Fortschr Med; 1999 Aug; 141(33):42-3. PubMed ID: 10766541
    [No Abstract]   [Full Text] [Related]  

  • 47. Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
    Blaivas JG
    Urology; 1988 Dec; 32(6 Suppl):5-11. PubMed ID: 2462303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical, urodynamic, and radiologic results in the study of prostatism with the PURR measure (passive urethral resistance ratio)].
    Adot Zurbano JM; Salinas Casado J; Virseda Chamorro M; Esteban Fuertes M; Samblas García R; Resel Estévez L
    Arch Esp Urol; 1995 Mar; 48(2):162-72. PubMed ID: 7538746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacourodynamic non-invasive studies in patients with prostatic adenoma].
    Danilov VV; Vasil'chenko AV; Danilova TI; Besedin SA; Borshchenko SA; Danilov VV
    Urologiia; 2010; (6):16-9. PubMed ID: 21427987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Editorial: benign prostatic hyperplasia.
    Djavan B
    Curr Opin Urol; 2013 Jan; 23(1):1. PubMed ID: 23202284
    [No Abstract]   [Full Text] [Related]  

  • 51. [Urodynamic study of obstructive uropathy due to benign prostatic hyperplasia].
    Fedel V; Povrzanović I; Fedel I
    Lijec Vjesn; 1992; 114(9-12):259-61. PubMed ID: 1285282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High flow infravesical obstruction in men: symptomatology, urodynamics and the results of surgery.
    Gerstenberg TC; Andersen JT; Klarskov P; Ramirez D; Hald T
    J Urol; 1982 May; 127(5):943-5. PubMed ID: 7086997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility.
    Song K; Choo MS; Lee KS; Han JY; Lee YS; Kim JC; Cho JS
    Urology; 2011 May; 77(5):1177-82. PubMed ID: 21256567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary tract symptoms: development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstruction.
    Rosier PF; de Wildt MJ; Wijkstra H; Debruyne FF; de la Rosette JJ
    J Urol; 1996 May; 155(5):1649-54. PubMed ID: 8627845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between the International Prostatic Symptom Score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia.
    Netto Júnior NR; D'Ancona CA; de Lima ML
    J Urol; 1996 Jan; 155(1):200-2. PubMed ID: 7490834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism.
    Yalla SV; Sullivan MP; Lecamwasam HS; DuBeau CE; Vickers MA; Cravalho EG
    J Urol; 1995 Mar; 153(3 Pt 1):674-9; discussion 679-80. PubMed ID: 7532231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Invasively estimated International Continence Society obstruction classification versus noninvasively assessed bladder outlet obstruction probability in treatment recommendation for LUTS suggestive of BPH.
    Boormans JL; van Venrooij GE; Boon TA
    Urology; 2007 Mar; 69(3):485-90. PubMed ID: 17382150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostate symptoms in general practice: seriousness and inconvenience.
    Wille-Gussenhoven MJ; de Bock GH; de Beer-Buijs MJ; Burgers SM; Buurman CM; Evenaar M; Springer MP
    Scand J Prim Health Care; 1997 Mar; 15(1):39-42. PubMed ID: 9101623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel natural fill telemetric pressure flow study of discomfort and bladder outlet obstruction.
    Kong HJ; Park S; Lee T; Lee JY; Kim HC; Oh SJ
    J Urol; 2009 Aug; 182(2):601-6. PubMed ID: 19535102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.